CUSIP 09077V100COMBIOAQ4 2025
11 filings · latest Feb 17, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | A16z Capital Management, L.L.C. | 3.23M | $44.07M |
| 2 | Sofinnova Investments, Inc. | 2.29M | $30.35M |
| 3 | Cormorant Asset Management, LP | 2.04M | $27.00M |
| 4 | Octagon Capital Advisors LP | 1.60M | $21.14M |
| 5 | Blackrock, Inc. | 1.53M | $20.21M |
| 6 | Vanguard Group Inc | 1.41M | $18.72M |
| 7 | Adage Capital Partners Gp, L.L.C. | 1.05M | $13.89M |
| 8 | Orbimed Advisors LLC | 790.9K | $10.46M |
| 9 |
| 4 | Aug 14, 2025 | Cormorant Asset Management, LP | 13G/A | 6.0% | 2.14M | SEC |
| 5 | Aug 14, 2025 | Adar1 Capital Management, LLC | 13G | 13.0% | 1.94M | SEC |
| 6 | Feb 14, 2025 | Ra Capital Management, L.P. | 13G/A | 3.7% | 1.31M | SEC |
| 7 | Feb 14, 2025 | Cormorant Asset Management, LP | 13G | 7.3% | 2.63M | SEC |
| 8 | Nov 14, 2024 | Khosla Ventures Vi, L.P. | 13G | 1.2% | 437.2K | SEC |
| 9 | Nov 12, 2024 | Fortney Kristen | 13G | 6.6% | 2.33M | SEC |
| 10 | Oct 7, 2024 | Ra Capital Management, L.P. | 13G | 6.2% | 2.21M | SEC |
See the full Schedule 13D/13G history for Bioage Labs Inc.
Unlock full history| Sands Capital Alternatives, LLC |
| 786.4K |
| $10.40M |
| 10 | Pivotal Bioventure Partners Investment Advisor LLC | 653.4K | $8.64M |